This powerful hybrid synth offers a different flavour to ASM’s all-conquering Hydrasynth. Greg Scarth checks it out.

Builds on positive Phase I safety data and represents a key value-inflection milestone for the CompanyAdvances a potentially ...

CONNECTA Therapeutics has commenced a Phase IIa trial to assess its lead programme, CTH120, a neuroplasticity modulator, in ...

WorldSBK will become the first production-based motorcycle championship to adopt carbon-ceramic brake discs under a new ...

The FDA approved capivasertib (Truqap) in combination with abiraterone (Zytiga) and prednisone for PTEN-deficient prostate cancer, the agency announced on Friday. Approval stipulates use in metastatic ...

H. Lundbeck A/S (Lundbeck) today announced that new data will be presented at the 2026 Endocrine Society's Annual Meeting (ENDO), taking place June 13–16 in Chicago, Illinois, U.S. Lundbeck will ...

Exosomes emerge as a potential alternative to stem cells in regenerative medicine, and early studies suggest roles in skin ...

Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced positive interim ...

Phase 2a study will evaluate the safety and biological activity of leronlimab in patients over the age of 50 with early-stage, ...

The firm cited growing clinical and mechanistic validation for aryl hydrocarbon receptor modulation in inflammatory bowel ...

Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss, today announced ...

Can practices focusing on breath enhance perception of inner and exterior conditions and modulate brain states?